Pfizer Asks FDA to Approve Their Covid-19 Vaccine for Children Aged 5 to 11
Pfizer and BioNTech asked the Food and Drug Administration on Thursday to approve their controversial COVID-19 vaccine for children aged 5-11.
The New York Times reports that “the agency has promised to move quickly on the request and has tentatively scheduled a meeting on Oct. 26 to consider it. A ruling is expected between Halloween and Thanksgiving.”
“With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against Covid-19,” Pfizer said in a statement on Thursday.
The Times report continues, “Pfizer has proposed giving children one-third of the adult dosage. That might require adding more diluent to each injection or using a different vial or syringe.
